Outcomes and health care utilization of older patients with acute myeloid leukemia

被引:5
|
作者
Sharplin, Kirsty [1 ]
Wee, Li Yan A. [1 ,2 ]
Singhal, Deepak [1 ,3 ]
Edwards, Suzanne [4 ]
Danner, Silke [1 ]
Lewis, Ian [3 ]
Thomas, Daniel [2 ]
Wei, Andrew [5 ,6 ]
Yong, Agnes S. M. [2 ,3 ]
Hiwase, Devendra K. [1 ,2 ,3 ]
机构
[1] Royal Adelaide Hosp, Haematol, Port Rd, Adelaide, SA, Australia
[2] South Australian Hlth & Med Res Inst, Precis Med Theme, Adelaide, SA, Australia
[3] Univ Adelaide, Fac Hlth Sci, Sch Med, Adelaide, SA, Australia
[4] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia
[5] Alfred Hosp, Dept Clin Hematol, Melbourne, Vic, Australia
[6] Monash Univ, Melbourne, Vic, Australia
关键词
AML; Older patients; Health care utilization; Chemotherapy; OF-LIFE CARE; RECEIVING INDUCTION CHEMOTHERAPY; INTENSIVE CHEMOTHERAPY; PALLIATIVE CARE; REMISSION-INDUCTION; ELDERLY-PATIENTS; GERIATRIC ASSESSMENT; EARLY DEATH; ADULTS; END;
D O I
10.1016/j.jgo.2020.07.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The incidence of acute myeloid leukemia (AML) in older patients is increasing, but practice guidelines balancing quality-of-life, time outside of hospital and overall survival (OS) are not established. Methods: We conducted a retrospective analysis comparing time outside hospital, OS and end-of-life care in AML patients >= 60 years treated with intensive chemotherapy (IC), hypomethylating agents (HMA) and best supportive care (BSC) in a tertiary hospital. Results: Of 201 patients diagnosed between 2005 and 2015, 54% received IC while 14% and 32% were treated with HMA and BSC respectively. Median OS was significantly higher in patients treated with IC and HMA compared with BSC (11.5 versus 16.2 versus 1.3 months; p < .0001). Median number of hospital admissions for the entire cohort was 3 (1-17) and patients spent <50% of their life after the diagnosis in the hospital setting. Compared to BSC, IC (HR 0.27, p < .0001) and HMA therapy (HR 0.16, p < .0001) were associated with the lower likelihood of spending at least 25% of survival time in hospital. Although 66% patients were referred to palliative care, the interval between referral to death was 24 (1-971) days and 46% patients died in the hospital. Conclusion: Older patients with AML, irrespective of treatment, require intensive health care resources, are more likely to die in hospital and less likely to use hospice services. Older AML patients treated with disease modifying therapy survive longer than those receiving BSC, and spend >50% of survival time outside the hospital. These data are informative for counselling older patients with AML. Crown Copyright (c) 2020 Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:243 / 249
页数:7
相关论文
共 50 条
  • [1] Health Care Utilization and End-of-Life Care for Older Patients With Acute Myeloid Leukemia
    El-Jawahri, Areej R.
    Abel, Gregory A.
    Steensma, David P.
    LeBlanc, Thomas W.
    Fathi, Amir T.
    Graubert, Timothy A.
    DeAngelo, Daniel J.
    Wadleigh, Martha
    Ballen, Karen K.
    Foster, Julia E.
    Attar, Eyal C.
    Amrein, Philip C.
    Brunner, Andrew M.
    Stone, Richard M.
    Temel, Jennifer S.
    [J]. CANCER, 2015, 121 (16) : 2840 - 2848
  • [2] Outcomes and Healthcare Utilization in Older Patients with Acute Myeloid Leukemia (AML)
    Sharplin, Kirsty
    Wee, Li Yan A.
    Edwards, Suzanne
    Danner, Silke
    Yong, Agnes S.
    Singhal, Deepak
    Hiwase, Devendra
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S224 - S224
  • [3] Health Care Utilization and End of Life Care for Older Patients with Acute Myeloid Leukemia Receiving Supportive Care Alone
    El-Jawahri, Areej
    Heavey, Sean F.
    LeBlanc, Thomas W.
    Vandusen, Harry
    Abel, Gregory
    Steensma, David P.
    Traeger, Lara
    Fathi, Amir T.
    DeAngelo, Daniel J.
    Wadleigh, Martha
    Hobbs, Gabriela
    Amrein, Philip C.
    Stone, Richard M.
    Ballen, Karen K.
    Chen, Yi-Bin
    Temel, Jennifer S.
    [J]. BLOOD, 2015, 126 (23)
  • [4] Outcomes for Older Patients with Acute Myeloid Leukemia Admitted to the Intensive Care Unit
    Keenan, Tanya
    LeBlanc, Thomas W.
    Traeger, Lara
    Vandusen, Harry
    Abel, Gregory A.
    Steensma, David P.
    Fathi, Amir T.
    DeAngelo, Daniel J.
    Wadleigh, Martha
    Hobbs, Gabriela
    Amrein, Philip C.
    Stone, Richard M.
    Ballen, Karen K.
    Chen, Yi-Bin
    Temel, Jennifer S.
    El-Jawahri, Areej
    [J]. BLOOD, 2015, 126 (23)
  • [5] Characteristics, outcomes and health care utilization of patients with acute myeloid leukemia aged 70 years or older: A single-center retrospective analysis
    Neumann, Marie Anne-Catherine
    Naendrup, Jan-Hendrik
    Borrega, Jorge Garcia
    Halmer, Ismini
    Altenrath, Lisa
    Sieg, Noelle
    Hallek, Michael
    Eichenauer, Dennis A.
    Heger, Jan-Michel
    [J]. HEMATOLOGICAL ONCOLOGY, 2024, 42 (05)
  • [6] Therapeutic outcomes of older patients with acute myeloid leukemia
    Sajid, Raihan
    Moiz, Bushra
    Ali, Natasha
    Kamran, Nausheen
    Adil, Salman N.
    Shaikh, Usman
    Khurshid, Mohammad
    [J]. SAUDI MEDICAL JOURNAL, 2010, 31 (05) : 533 - 538
  • [7] Factors Associated with Health Care Utilization at the End of Life for Patients with Acute Myeloid Leukemia
    Vaughn, Dagny M.
    Johnson, P. Connor
    Jagielo, Annemarie D.
    Topping, Carlisle E. W.
    Reynolds, Matthew J.
    Kavanaugh, Alison R.
    Webb, Jason A.
    Fathi, Amir T.
    Hobbs, Gabriela
    Brunner, Andrew
    O'Connor, Nina
    Luger, Selina
    Bhatnagar, Bhavana
    LeBlanc, Thomas W.
    El-Jawahri, Areej
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2022, 25 (05) : 749 - 756
  • [8] Outcomes for Older Patients with Acute Myeloid Leukemia after Admission to the Intensive Care Unit (ICU)
    Slavin, Samuel
    Brunner, Andrew M.
    Steensma, David P.
    Fathi, Amir T.
    DeAngelo, Daniel J.
    Wadleigh, Martha
    Hobbs, Gabriela S.
    Amrein, Philip C.
    Stone, Richard M.
    Temel, Jennifer S.
    Abel, Gregory A.
    El-Jawahri, Areej
    [J]. BLOOD, 2018, 132
  • [9] Older patients with acute myeloid leukemia
    Yee, Karen W. L.
    Keating, Armand
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2010, 3 (06) : 755 - 774
  • [10] Initial therapy for acute myeloid leukemia in older patients: principles of care
    Bhatt, Vijaya Raj
    Gundabolu, Krishna
    Koll, Thuy
    Maness, Lori J.
    [J]. LEUKEMIA & LYMPHOMA, 2018, 59 (01) : 29 - 41